Late cardiotoxicity following anthracycline therapy for childhood cancer
Open Access
- 1 January 1998
- journal article
- Published by Elsevier in Progress in Pediatric Cardiology
- Vol. 8 (3), 121-138
- https://doi.org/10.1016/s1058-9813(98)00008-3
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- Cardiovascular responses to dynamic submaximal exercise in children previously treated with anthracyclineAmerican Heart Journal, 1997
- Cardiac transplantation in childhood cancer survivors in Great BritainEuropean Journal Of Cancer, 1996
- Myocardial function in children and adolescents after therapy with anthracyclines and chest irradiationEuropean Journal Of Cancer, 1996
- Late effects of anthracycline therapy in childhood in relation to the function of the heart at rest and under physical stressEuropean Journal of Pediatrics, 1995
- Functional cardiac disturbances related to chemotherapy independent of anthracycline use in children with neoplastic diseaseThe American Journal of Cardiology, 1995
- Limitations of fractional shortening as an index of contractility in pediatric patients infected with human immunodeficiency virusThe Journal of Pediatrics, 1994
- Ventricular late potentials: another expression of cardiotoxicity of cytostatic drugs in children?International Journal of Cardiology, 1992
- Electrocardiographic changes and arrhythmias after cancer therapy in children and young adultsThe American Journal of Cardiology, 1992
- Echocardiographic measurements in normal subjects from infancy to old age.Circulation, 1980
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978